FI950696L - Menetelmä HIV:n replikaation estämiseksi IL-4:ää käyttämällä - Google Patents

Menetelmä HIV:n replikaation estämiseksi IL-4:ää käyttämällä Download PDF

Info

Publication number
FI950696L
FI950696L FI950696A FI950696A FI950696L FI 950696 L FI950696 L FI 950696L FI 950696 A FI950696 A FI 950696A FI 950696 A FI950696 A FI 950696A FI 950696 L FI950696 L FI 950696L
Authority
FI
Finland
Prior art keywords
hiv replication
inhibiting hiv
inhibiting
replication
hiv
Prior art date
Application number
FI950696A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI950696A7 (fi
FI950696A0 (fi
Inventor
Jerome Schwartz
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of FI950696A7 publication Critical patent/FI950696A7/fi
Publication of FI950696A0 publication Critical patent/FI950696A0/fi
Publication of FI950696L publication Critical patent/FI950696L/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/20Interleukins [IL]
    • A61K38/2026IL-4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
FI950696A 1992-08-19 1993-08-17 Menetelmä HIV:n replikaation estämiseksi IL-4:ää käyttämällä FI950696L (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US93213492A 1992-08-19 1992-08-19
PCT/US1993/007587 WO1994004179A1 (en) 1992-08-19 1993-08-17 Method for inhibiting hiv replication using il-4

Publications (3)

Publication Number Publication Date
FI950696A7 FI950696A7 (fi) 1995-02-16
FI950696A0 FI950696A0 (fi) 1995-02-16
FI950696L true FI950696L (fi) 1995-02-16

Family

ID=25461831

Family Applications (1)

Application Number Title Priority Date Filing Date
FI950696A FI950696L (fi) 1992-08-19 1993-08-17 Menetelmä HIV:n replikaation estämiseksi IL-4:ää käyttämällä

Country Status (22)

Country Link
US (1) US5700461A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0656785B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JP2711182B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR950702838A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN (1) CN1086437A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE163860T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU683427B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2142862C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CZ (1) CZ38095A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE69317428T2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2113549T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI950696L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HUT72709A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL106717A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MX (1) MX9305016A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO950599L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ255735A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PL (1) PL307508A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SK (1) SK21295A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TW (1) TW291439B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO (1) WO1994004179A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA936018B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE262920T1 (de) 1995-11-02 2004-04-15 Schering Corp Kontinuierliche, niedrigdosierte zytokine- infusionstherapie
US20050124645A1 (en) * 1998-04-20 2005-06-09 Finkel Terri H. Methods and compositions for increasing CD4lymphocyte immune responsiveness
US20030232738A1 (en) * 1998-04-20 2003-12-18 National Jewish Medical And Research Center Method and composition for increasing CD4+ T lymphocyte immune responsiveness
US20040132161A1 (en) * 1998-04-20 2004-07-08 Finkel Terri H. Methods and compositions for increasing CD4lymphocyte immune responsiveness
BR9911457A (pt) * 1998-06-24 2001-12-11 Univ Emory Uso de 3'-azida-2', 3'-dideoxiuridina em combinaçãocom drogas anti-hiv adicionais para a manufaturade um medicamento para o tratamento de hiv
US6734192B1 (en) * 1999-08-23 2004-05-11 Mp-1 Inc. Treatment of viral infections

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4724232A (en) * 1985-03-16 1988-02-09 Burroughs Wellcome Co. Treatment of human viral infections
JPH02485A (ja) * 1987-08-03 1990-01-05 Yuu Honshiyo 新規なヒトインターロイキン4、該因子を発現させるための組換えベクター及びそのベクターにより形質転換された形質転換体
US5011829A (en) * 1989-06-02 1991-04-30 G. D. Searle & Co. Pharmaceutical composition and method of inhibiting virus
ATE133074T1 (de) * 1990-03-21 1996-02-15 Schering Corp Verwendung von il-4 zur verstärkung der immunantwort auf infektiöse antigen- herausforderungen
US5206345A (en) * 1990-08-02 1993-04-27 Fred Hutchinson Cancer Research Center Il-4 and tnf induce mab 6g10-recognized expression on bone marrow stromal cells
EP0490006B1 (en) * 1990-12-13 1994-06-22 Schering-Plough Pharmaceutical compositions for the treatment of B-cell malignancies

Also Published As

Publication number Publication date
WO1994004179A1 (en) 1994-03-03
ES2113549T3 (es) 1998-05-01
NO950599D0 (no) 1995-02-17
FI950696A7 (fi) 1995-02-16
US5700461A (en) 1997-12-23
MX9305016A (es) 1994-02-28
IL106717A0 (en) 1993-12-08
NZ255735A (en) 1997-06-24
JP2711182B2 (ja) 1998-02-10
NO950599L (no) 1995-02-17
CZ38095A3 (en) 1995-12-13
SK21295A3 (en) 1997-01-08
CA2142862C (en) 2000-05-30
EP0656785A1 (en) 1995-06-14
FI950696A0 (fi) 1995-02-16
AU5007593A (en) 1994-03-15
CA2142862A1 (en) 1994-03-03
TW291439B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1996-11-21
HU9500487D0 (en) 1995-04-28
ZA936018B (en) 1994-06-13
PL307508A1 (en) 1995-05-29
DE69317428D1 (de) 1998-04-16
CN1086437A (zh) 1994-05-11
HUT72709A (en) 1996-05-28
EP0656785B1 (en) 1998-03-11
KR950702838A (ko) 1995-08-23
DE69317428T2 (de) 1998-07-02
JPH07506116A (ja) 1995-07-06
ATE163860T1 (de) 1998-03-15
AU683427B2 (en) 1997-11-13

Similar Documents

Publication Publication Date Title
FI944619A7 (fi) Aldolisointi-dehydratointimenetelmä
FI951596L (fi) Menetelmä 10-desasetyylibakkatiini-III:n saamiseksi
FI930455A7 (fi) Yhdisteitä ja menetelmiä geeniekspression inhiboimiseksi
FI952436A7 (fi) Menetelmä valoherkkien aineiden aktivoimiseksi
FI920703A7 (fi) Menetelmä laminaatin valmistamiseksi
FI945441L (fi) Uusi menetelmä 7beta-substituoitu-4-atsa-5alfa-androstan-3-onien valmistamiseksi
NO921218D0 (no) Reseptor-rensemetode
FI941046A7 (fi) Farmaseuttinen menetelmä
DK0635004T3 (da) 4-Diphenylmethylpiperidinderivater og fremgangsmåde til fremstilling deraf
FI921621L (fi) Sprutmetod foer braensle
FI931740L (fi) Semisyntetiska glukosaminoglykaner innehaollande a-l-galakturonsyra somaer substituerad i 3-staellning med nukleofila radikaler
NO931535L (no) Bifenylmetylsubstituerte pyridoner
FI950696A7 (fi) Menetelmä HIV:n replikaation estämiseksi IL-4:ää käyttämällä
DK96392D0 (da) Modifikationsmetode
FI933816L (fi) Understaell foer raelsfordon
FI933276A7 (fi) 3-aminoetyyli-indoleista johdettuja amidiineja ja menetelmä niiden valmistamiseksi
DE69222869D1 (de) Verbrennungsvorrichtung
DE69309870D1 (de) Drehverfahren
KR930023719U (ko) 캐이슨(caisson)용 들고리
FI934284A7 (fi) Menetelmä vaneerin valmistamiseksi
FI932146A7 (fi) Menetelmä 5-kloorioksi-indolin valmistamiseksi
DK0587480T3 (da) Deponeringsindretning
LV10027A (lv) Broileru edinasanas metode
NO931503D0 (no) Peptidbaserte inhibitorer av hiv-replikasjon
IT227807Y1 (it) Gruppo punzone

Legal Events

Date Code Title Description
FC Application refused
FD Application lapsed